Professional Documents
Culture Documents
Continuing Nursing
Education
Zorica Kauric-Klein
n the United States, cardiovascular
disease accounts for almost 50% of
deaths in patients with renal disease
(United States Renal Data System
[USRDS], 2010). Hypertension in
patients on chronic hemodialysis (HD)
contributes significantly to their morbidity and mortality (Agarwal, 2005).
Hypertension is very prevalent among
patients undergoing chronic HD.
Statistics indicate the prevalence of
hypertension in patients on chronic
HD is approximately 75% to 100%
(Agarwal et al., 2003; Horl & Horl,
2002; Mittal et al., 1999; Morse, Dang,
Thakur, Zhang, & Reisin, 2003;
USRDS, 2010). Uncontrolled hypertension may result in left ventricular
hypertrophy, coronary artery disease,
congestive heart failure, and cerebrovascular complications (Cheigh,
Milite, Sullivan, Rubin, & Stenzel,
1992; Rocco, Yan, Heyka, Benz &
Cheung, 2001).
The National Kidney Foundation
(NKF) Task Force on Cardiovascular
Disease in Chronic Kidney Disease
(CKD) has targeted hypertension as a
major risk factor in the management
of cardiovascular disease (CVD)
(NKF, 2004). Targeting a reduction in
deaths due to cardiovascular causes
Goal
To provide an overview of how supportive nursing intervention incorporating monitoring,
goal setting, and reinforcement can improve blood pressure control in a chronic
hemodialysis population.
Objectives
1. Review the statistical data of cardiovascular morbidity and mortality as they relate to
the individual undergoing hemodialysis.
2. Determine nursing interventions that can improve blood pressure control in a chronic
hemodialysis population.
3. Describe how the use of self-efficacy, self-regulation, and self-care can assist in the
management of hypertension.
This offering for 1.5 contact hours is provided by the American Nephrology Nurses
Association (ANNA).
ANNA is a provider approved by the California Board of Registered Nursing, provider number
CEP 00910.
Accreditation status does not imply endorsement by ANNA or ANCC of any commercial product.
This CNE article meets the Nephrology Nursing Certification Commissions (NNCCs) continuing nursing education requirements for certification and recertification.
May-June 2012
217
Improving Blood Pressure Control in End Stage Renal Disease Through a Supportive Educative Nursing Intervention
218
Instruments
The following study variables
were measured quantitatively: BP
control in HD knowledge, BP control
self-efficacy, BP control self-regulation, BP control self-care behaviors,
social support, and blood pressure.
Demographic data were obtained
from the baseline review of the chart
and investigator interviews of the participants. An investigator-developed
general demographic information
questionnaire was used to collect
information on the following demographic variables: age, gender, race,
comorbidities, income, and education. Since depression may affect an
individuals ability to participate in
BP self-care behaviors, it was also
measured.
Depression
Depression has been found to be
associated with decreased adherence
to BP self-care behaviors, such as
fluid restrictions, nutrition, and medication (Akman et al., 2007; Kimmel,
2002; Taskapan et al., 2005); thus, the
variable was further explored in this
study. Depression was measured
using the five-minute, nine-item
PHQ-9. According to the PHQ-9, a
score of 10 would be considered
May-June 2012
Social Support
Social support has been found to
affect participation in self-care behaviors in the HD population (Mitchell et
al., 2003). Social support in this sample
was measured using the ENRICHD
Social Support Instrument (ESSI). The
ESSI is a five-minute, self-administered, seven-item questionnaire that
primarily measures functional social
support, and in particular, emotional
support. It has primarily been used in
patients with cardiac disease. Possible
scores can range from 8 to 34, with
higher scores indicating greater social
support. Reliability and validity have
been established in a sample of 196
patients post-myocardial infarction
(Mitchell et al., 2003).
BP Self-Care Behaviors
BP self-care behaviors measured
were fluid intake, sodium intake, BP
medication adherence, and HD adherence.
Fluid Intake
BP Control Self-Regulation
BP Control Self-Monitoring
Sodium Intake
BP Control Self-Evaluation/
Self-Reinforcement
May-June 2012
Medication Adherence
The Morisky Scale (Morisky,
Green, & Levine, 1986) was used to
measure adherence to antihyperten-
219
Improving Blood Pressure Control in End Stage Renal Disease Through a Supportive Educative Nursing Intervention
Hemodialysis Adherence
HD adherence was determined
as total number of HD treatments
missed over 12 weeks. In this study,
HD nonadherence refers to missing
any HD treatments.
Blood Pressure
Average BP was measured in the
treatment and control groups at baseline, 12 weeks, and 16 weeks. In both
the experimental and control groups,
average BP was operationalized by
averaging three weekly pre-HD BPs
from the HD flow sheets.
Design
A 90-day randomized controlled
design was used to determine if a supportive nursing education intervention improved BP control in a chronic HD population. Six HD units were
randomized to intervention or control
by flipping a coin. Data were collected at baseline, 12 weeks, and 16 weeks.
220
Procedure
After approval from Wayne State
University Institutional Review Board
(IRB) and the HD units, the HD staff
and physician in charge were in-serviced by the principal investigator of
the study. After the medical director
or nurse manager identified participants who were interested and eligible to participate in the study, the
principal investigator explained the
study to each of the potential participants in detail and provided the
opportunity to ask and answer questions. Potential patients interested in
Intervention
The intervention consisted of 1)
two BP education sessions; 2) 12week monitoring, goal setting, and
reinforcement; and 3) a 30-day postintervention follow-up period. Predetermined goals based on NKF
(2004) KDOQI clinical guidelines for
hypertension in ESRD were established by the investigator and
reviewed with each participant prior
to the initiation of the study. The goals
were a) pre-HD BP less than140/90
mmHg and post-HD BP less than
130/80 mmHg for the entire duration
of the study (16 weeks), b) sodium
intake (less than 2 grams/day or 1 teaspoon/day), c) fluid intake (less than
1500 ml/day) or less than 2.5 kg
weight gain in between HD treatment, d) 100% adherence to HD regimen, and e) 100% adherence to medication regimen.
The treatment group received
two educational sessions. The content
of the educational sessions was developed by the investigator and based on
the NKF (2004) clinical guidelines for
hypertension in ESRD. The main
objectives of the first educational session were to explain the underlying
pathophysiology of hypertension in
ESRD, identify risks associated with
having hypertension in ESRD,
describe the self-care interventions/
goals that could improve BP control,
and describe the role of self-regulation in changing behavior related to
BP control.
May-June 2012
Data Management
All data were checked twice to
ensure that no data were missing and
that scores from the instruments fell
within the instrument scoring range.
Demographic data and data from
questionnaires were coded and
entered into SPSS 17.0 data entry by
the investigator.
Results
The demographic characteristics
of the sample are described in Table
1. An equal number of participants
participated in the control group (n =
59) and the treatment group (n = 59).
The participants in this sample were
predominately African American, not
well educated, with an average age of
60 years. Almost half of the sample
earned a total household yearly in-
May-June 2012
Co-Morbid Conditions
In terms of co-morbidities, 50%
of the sample had diabetes, 33% of the
sample had pre-existing atherosclerotic heart disease, and 25% of the
sample had congestive heart failure
(CHF). The only significant co-morbid condition between the two groups
was CHF, which was more prevalent
in the treatment group.
BP Medications
The majority of participants were
taking blood pressure medications (n
= 114, 96.6%), with half of the sample
taking three or more medications to
help control their BP. Only four participants (3.4%) were not taking any
BP medications. The frequencies of
medications taken (by class) and by
each group of study participants are
shown in Table 2. The only significant
difference between the groups in BP
medication use was diuretics (F[1.116]
= 7.3, p = 0.008). In the treatment
group, 19% of the participants were
taking a diuretic compared to 3% (n =
2) in the control.
BP Self-Care Capabilities
BP knowledge. Participants had
fairly good levels of knowledge about
BP control behaviors at baseline, and
there was no significant improvement
in scores at 12 weeks (t = 1.2, p = 0.25)
(see Table 3). At baseline, the treatment group (M = 42.5, SD = 4.7) had
a statistically significant lower BP
knowledge score than the control
group (M = 44.5, SD = 4.1) (t = 2.4, p
= .02). At 12 weeks, the treatment
groups score increased slightly to
43.4 (SD = 5.5), with no change in the
control groups score of 44.4 (SD =
3.8) (91% correct).
BP control self-efficacy. At
baseline, the treatment group had a
higher BP self-efficacy score (M = 49,
221
Improving Blood Pressure Control in End Stage Renal Disease Through a Supportive Educative Nursing Intervention
Table 1
Frequency Distributions Demographic Characteristics of the Sample (N = 118)
Intervention Group
(n = 59)
M (SD)/Frequency (%)
Control Group
(n = 59)
M(SD)/Frequency (%)
t-Test/Chi Square
63.4
(16.4)
56
(14.8)
-2.60
0.01
Male
28
(47.0)
32
(54.0)
0.54
0.46
Female
31
(53.0)
27
(46.0)
African American
42
(71.0)
59 (100.0)
19.80
0.00
Caucasian
14
(23.7)
(0.0)
(5.0)
(0.0)
(1.6)
11
(18.6)
20.80
0.00
$5,000-$9,999
20
(33.8)
26
(44.0)
$10,000-$19,999
14
(23.7)
15
(25.4)
$20,000-$29,000
12
(20.3)
(10.0)
$30,000-$49,999
(11.8)
(0.0)
(8.5)
(1.6)
10.70
0.64
4.50
0.10
3.60
0.06
Variable
Age
Gender
Race
Middle Eastern
Income
Less than $5,000
Educational Level
Less than grade 8
(3.4)
(6.8)
11
(18.6)
15
(25.4)
15
(25.4)
15
(25.4)
Some college
20
(33.8)
21
(35.6)
College graduate
11
(18.6)
(6.7)
Not employed
47
(80.0)
52
(88.1)
Part-time
11
(18.6)
(6.8)
Full-time
(1.7)
(5.0)
Yes
27
(45.8)
17
(28.8)
No
32
(54.2)
42
(71.1)
Employment
Table 2
Frequency Distributions Blood Pressure Medications (N = 118)
Variable
Treatment Group
Frequency (%)
(n = 59)
Control Group
Frequency (%)
(n = 59)
Chi Square
Diuretic
11
(18.6)
(3.4)
7.0
0.01
Beta-blockers
49
(83.1)
45
(76.3)
0.84
0.36
Ace inhibitors
25
(42.3)
33
(55.9)
2.2
0.14
16
(27.0)
(15.3)
2.5
0.12
35
(59.3)
30
(51.0)
0.85
0.36
Alpha blockers
27
(46.0)
21
(35.6)
1.3
0.26
222
May-June 2012
Table 3
Study Variables Summary Statistics (N =118)
Baseline
Mean (SD)
Between
Group
t-Test (p)
Treatment (n = 59)
30.2 (5.0)
-2.1 (0.04)
Control (n = 59)
28.4 (4.3)
Variable
12-Week
Follow Up,
Mean (SD)
12-Week
Within Group
t-Test (p)
12-Week
Between Group
t-Test (p)
11 (1.5)
0.17 (0.87)
-1.6, (0.11)
10.5 (1.2)
3.2 (0.00)
43 (6.5)
-0.74 (0.47)
44.5 (4.1)
0.32 (0.75)
49.4 (4.0)
-1.0 (0.32)
48.7 (4.8)
-3.1 (0.00)
Social Support
Depression
Treatment (n = 59)
11 (1.7)
Control (n = 59)
11 (1.5)
-0.12 (0.91)
BP Knowledge
Treatment (n = 59)
42.5 (4.7)
Control (n = 59)
44.5 (4.1)
2.4 (0.02)
1.4, (0.16)
BP Self-Efficacy
Treatment (n = 59)
Control (n = 59)
49 (4.2)
47.5 (4.4)
-1.8 (0.07)
-0.86, (0.07)
Table 4
Self-Monitoring Behaviors Adherence to Logs (n = 59)
Average Logs
Recorded Mean
(Range)
Logs
Recommended
Adherence
Rate (%)
76 (0 to 180)
180
42
Sodium
1.3 (0 to 6)
12
11
Fluid
1.4 (0 to 12)
12
12
Logs
Blood Pressure
May-June 2012
223
Improving Blood Pressure Control in End Stage Renal Disease Through a Supportive Educative Nursing Intervention
At 16 weeks, fluid gains were not significantly different between the control (M = 2.46, SD = 1.01) and treatment groups (M = 2.42, SD = 1.1)
(t[115] = 0.208, p = 0.84). There were
no significant differences within each
group for fluid gains from baseline to
12 or 16 weeks
Sodium intake. The average sodium intake score based on the sodium
intake checklists for the treatment
group was 14.8 (SD = 8.7), indicating
a low sodium intake with a range of 4
to 53 (see Table 6). The average sodium intake score decreased from a
mean of 18.5 (SD = 10.9) at baseline
to 13.5 (SD = 5.0) at 12 weeks.
Repeated measures ANOVA were
conducted and found no significant
pattern of change in sodium intake
over 12 weeks (F[5] = 2.6, p = 1.6).
BP medication adherence. At base-
Table 5
Self-Evaluation/Reinforcement Behaviors (n = 59)
Weekly Goals Met
M (SD)
Goal
Range
(Min Max)
Blood Pressure
4.3
(3.2)
12
0 to 12
36
Fluid
7.3
(4.4)
12
0 to 12
61
6 (0.8)
1
5 to 6
94
Sodium
Table 6
Blood Pressure Self-Care Behaviors (N = 118)
Variable
Baseline
M (SD)
Individual
t-Test (p)
12-Week
M (SD)
Individual
t-Test (p)
Paired
t-Test (p)
16-Week
M (SD)
Individual
t-Test (p)
Paired
t-Test (p)
0.23 (0.82)
2.40 (1.10)
0.37 (0.72)
0.01 (0.96)
2.4 (1.2)
0.14 (0.89)
0.13 (0.90)
-0.38 (0.70)
2.5 (1.0)
2.4
(1.2)
Control
2.5 (0.86)
2.50 (0.97)
0.23 (0.82)
18.5 (10.9)
13.5
(5.0)
Medication Adherence
Treatment
0.83
Control
0.88 (0.93)
(1.0)
0.28 (0.78)
0.78 (0.98)
1.00 (0.30)
0.98 (1.10)
0.44 (0.67)
-0.76 (0.45)
0.75 (0.99)
Control
1.40 (1.70)
224
2.40 (0.02)
May-June 2012
Figure 1
Blood Pressure at Baseline, 12 Weeks and 16 Weeks
170
Control
SBP
160
150
Treatment
SBP
140
130
Control
DBP
120
110
Treatment
DBP
100
90
80
70
Baseline
12 Weeks
Blood Pressure
The average systolic BP did not
significantly differ between the two
groups at baseline (t[106] = 0.51, p =
0.61). At baseline, the average systolic
BP of the control group was 164
mmHg (SD = 14.2) and 163 mmHg
(SD = 10.3) in the treatment group.
However, there was a significant difference between the two groups in
diastolic BP (t[116] = 2.7, p = 0.008) at
baseline. The baseline diastolic BP
was higher in the control group (M =
89.9 mmHg, SD =10.7) than the diastolic BP in the treatment group (M =
84.9 mmHg, SD = 9.0).
16 Weeks
Hypothesis 1: Patients on
chronic HD randomized to a 90day supportive educative intervention will have a decrease in
systolic BP at 12 and 16 weeks
compared to the usual care group.
Overall, there was a significant difference in systolic BP between treatment
and control groups at 12 weeks (t =
3.02, p = 0.003) and 16 weeks (t =
2.53, p = 0.013), with the treatment
group having significantly lower systolic BP (see Figure 1). At 12 weeks,
the treatment groups average systolic
BP was 155 mmHg (SD = 10.5) compared to 161.9 mmHg (SD = 13.5) in
the control group. At 16 weeks, the
treatment groups average systolic BP
remained significantly lower at 153.5
mmHg (SD = 12.2) compared to 160
mmHg in the control group (SD =
14.8) (see Figure 1).
Paired t-tests were conducted to
determine if there was a significant
decrease in systolic BP from baseline
to 12 and 16 weeks within both
groups. There was a significant
decrease in systolic BP in the treatment group from baseline to 12 weeks
(t[58] = 7.0, p = 0.00). The treatment
groups systolic BP decreased from
163 mmHg (SD = 10.3) to 155 mmHg
(SD = 10.5) at 12 weeks and continued to decrease to 153.5 mmHg at 16
weeks. Overall, there was a significant
May-June 2012
225
Improving Blood Pressure Control in End Stage Renal Disease Through a Supportive Educative Nursing Intervention
226
and stepwise) was conducted to determine the optimal model. The combination of the following three variables
significantly contributed to the prediction of systolic BP: total BP goals
met ( = -0.45, p = 0.01), missed HD
treatments ( = 2.6, p = 0.01), and
medication change ( = 0.32, p =
0.04), explaining 44% of the variance
in systolic BP. According to Cohen,
Cohen, West, and Aiken (2003), this
is a large effect.
Covariates. Multiple regression
was also conducted to determine the
best linear combination of variables
(BP knowledge, BP control self-efficacy, BP self-regulation, average fluid
gains, average sodium intake, medication adherence, medication changes,
and missed HD treatments) in predicting diastolic BP. Step-type regression (forwards, backwards, and stepwise) was conducted to determine the
optimal model. Two of the variables
missed HD treatments ( = 0.39, p =
0.00), and total BP goals achieved
( = -0.38, p = 0.00) predicted 30% of
the variance in diastolic BP.
Discussion
This study evaluated whether a
supportive nursing intervention incorporating self-regulation components could improve BP control in a
chronic HD population. Both systolic
and diastolic BP significantly decreased in the treatment group. The
exact mechanism of how the intervention improved systolic BP and
diastolic BP is not clear; however, it
appears that the intervention improved systolic and diastolic BPs
through BP goal achievement and
reinforcement, improved HD adherence, and increased medication
changes within the treatment group.
Limitations
One limitation of the study was
the randomization process. Because
of the fear of diffusion of the intervention across units, the randomization
process was carried out by HD units.
The control and treatment groups
were drawn from two different demographic areas (inner-city verses subur-
May-June 2012
Conclusions
The findings in this study indicate
that a supportive nursing intervention
that provided BP education, monitored weekly achievement of goals,
and reinforced achievement of goals
improved BP outcomes. Nurses can
implement interventions such as
those outlined in this study. Nephrology nurses are the healthcare providers who have the most interaction
with patients on dialysis and are most
familiar with the behaviors of patients
on dialysis related to BP control, and
they are in the best position to implement interventions such as these.
They can teach, guide, and support
patients who are hypertensive in
monitoring home BP, reviewing BP
goals on a weekly basis, and positively reinforcing patients when BP goals
are met. They can also offer further
guidance and problem solving for
possible reasons goals were not met
(such as excessive fluid gains, missed
medications). Medication adherence
was strongly linked to BP outcomes;
therefore, nurses should also be
encouraged to promote medication
adherence with their patients.
The intervention did not improve BP knowledge or BP self-efficacy in the treatment group. Since literature has consistently indicated that
education alone does not produce
behavior change, health professionals
should not rely on educational materials alone to change behaviors in this
population. Nurses can use other
interventions in addition to education, such as monitoring, goal setting,
May-June 2012
227
Improving Blood Pressure Control in End Stage Renal Disease Through a Supportive Educative Nursing Intervention
228
Additional Reading
Sensky, T., Leger, C., & Gilmour, S.
(1996). Psychosocial and cognitive
factors associated with adherence to
dietary and fluid restriction regimens
by people on chronic hemodialysis.
Psychotherapy and Psychosomatics, 65(1),
36-42.
May-June 2012
ANNJ1211
ANSWER/EVALUATION FORM
Improving Blood Pressure Control in End Stage Renal Disease Through
A Supportive Educative Nursing Intervention
Zorica Kauric-Klein, PhD, RN, APRN-BC, ANCC
1.5 Contact Hours
Expires: June 30, 2014
ANNA Member Price: $15
Regular Price: $25
Posttest Instructions
Complete the evaluation.
Send this page to the ANNA National
Office; East Holly Avenue Box 56;
Pitman, NJ 08071-0056, or fax this
form to (856) 589-7463.
Enclose a check or money order
payable to ANNA. Fees listed in
payment section.
A certificate for the contact hours will
be awarded by ANNA.
Please allow 2-3 weeks for processing.
You may submit multiple answer forms
in one mailing; however, because of
various processing procedures for
each answer form, you may not receive
all of your certificates returned in one
mailing.
Payment:
ANNA Member: ____ Yes ____ No
Check Enclosed
Member #___________________________
American Express
Visa
MasterCard
Strongly
disagree
Evaluation
2. By completing this offering, I was able to meet the stated objectives
a. Review the statistical data of cardiovascular morbidity and mortality as they relate to the individual
undergoing hemodialysis.
b. Determine nursing interventions that can improve blood pressure control in a chronic hemodialysis
population.
c. Describe how the use of self-efficacy, self-regulation, and self-care can assist in the management
of hypertension.
3. The content was current and relevant.
4. This was an effective method to learn this content.
5. Time required to complete reading assignment: _________ minutes.
6. I am more confident in my abilities since completing this material.
Strongly
agree
1
1
1
2
2
2
3
3
3
4
4
4
5
5
5
May-June 2012
229
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.